Viewing Study NCT04222920


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-01-29 @ 12:03 AM
Study NCT ID: NCT04222920
Status: COMPLETED
Last Update Posted: 2023-11-18
First Post: 2020-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease Activity
Sponsor: Reade Rheumatology Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module